Literature DB >> 15338343

Surgical management of substernal goiters: clinical experience of 170 cases.

Yesim Erbil1, Alp Bozbora, Umut Barbaros, Selcuk Ozarmağan, Adil Azezli, Senay Molvalilar.   

Abstract

PURPOSE: To discuss the presentation, diagnosis, treatment, histopathological findings, and complications of patients who underwent thyroidectomy for substernal goiter in our surgical clinic.
METHODS: We retrospectively analyzed 170 patients with substernal goiters among 2650 patients undergoing surgical treatment for various thyroid diseases between 1990 and 2003. We evaluated the clinical data, preoperative diagnostic findings, surgical treatments, histopathological results, and postoperative complications.
RESULTS: The most common symptoms were a cervical mass (88%) and dyspnea (35%), but 26% of the patients were asymptomatic. Chest radiography provided the first evidence of a substernal goiter in 77% of the patients. We performed total or near total thyroidectomy and operated through a cervical incision in all but 12 of the patients. There was no operative mortality but 12 (7%) patients suffered temporary hypoparathyroidism and 4 suffered transient vocal cord paralysis (2%). Malignancy was diagnosed by histopathological examination in 22 (13%) patients.
CONCLUSION: We think that the diagnosis of a substernal goiter is an indication for thyroidectomy, which is associated with very low postoperative morbidity.

Entities:  

Mesh:

Year:  2004        PMID: 15338343     DOI: 10.1007/s00595-004-2823-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  23 in total

1.  Management of retrosternal goitres.

Authors:  R G Hardy; R D Bliss; T W J Lennard; S P Balasubramanian; B J Harrison
Journal:  Ann R Coll Surg Engl       Date:  2009-01       Impact factor: 1.891

2.  Scabbard Trachea in a Case of Retrosternal Goitre.

Authors:  Shreya Sengupta; Ramanuj Mukherjee; Sayantan Bose; Gouri Mukhopadhyay
Journal:  Indian J Surg       Date:  2017-08-13       Impact factor: 0.656

3.  Surgical approach to retrosternal goitre: do we still need sternotomy?

Authors:  M G Rugiu; M Piemonte
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

4.  Effect of hospital volume of thyroidectomies on outcomes following substernal thyroidectomy.

Authors:  Fredric M Pieracci; Thomas J Fahey
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

5.  The "forgotten" goiter after total thyroidectomy.

Authors:  Alper Sahbaz; Nihat Aksakal; Beyza Ozcinar; Feyyaz Onuray; Kasim Caglayan; Yesim Erbil
Journal:  Int J Surg Case Rep       Date:  2012-12-07

6.  Cervical compression due to benign thyroid disorders is not associated with increased postoperative morbidity.

Authors:  Peter Ambe; Katharina Lindecke; W T Knoefel; Alexander Rehders
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-17       Impact factor: 2.503

7.  Thyroidectomy using monitored local or conventional general anesthesia: an analysis of outpatient surgery, outcome and cost in 1,194 consecutive cases.

Authors:  Kathryn Spanknebel; John A Chabot; Mary DiGiorgi; Kenneth Cheung; James Curty; John Allendorf; Paul LoGerfo
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

8.  Surgical management of mediastinal goiter: risk factors for sternotomy.

Authors:  Stanisław Cichoń; Ryszard Anielski; Aleksander Konturek; Marcin Baczyński; Wojciech Cichoń; Paweł Orlicki
Journal:  Langenbecks Arch Surg       Date:  2008-05-17       Impact factor: 3.445

9.  Necessity for additional incisions with the cervical collar incision to remove retrosternal goiters.

Authors:  Salih Topcu; Serife Tuba Liman; Zafer Canturk; Zafer Utkan; Zeynep Canturk; Selin Corak; Berrin Cetinarslan
Journal:  Surg Today       Date:  2008-11-28       Impact factor: 2.549

10.  Surgical treatment of substernal goiter: an analysis of 59 patients.

Authors:  Ayman Agha; Gabriel Glockzin; Nabil Ghali; Igors Iesalnieks; Hans J Schlitt
Journal:  Surg Today       Date:  2008-05-31       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.